Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Hudbay Minerals Inc. Ordinary Shares (Canada) (HBM) Price & Performance

Halozyme Therapeutics Inc. Common StockTrade
Hudbay Minerals Inc. Ordinary Shares (Canada)Trade

Price performance (Past 24H)

Key statistics

Halozyme Therapeutics Inc. Common Stock vs Hudbay Minerals Inc. Ordinary Shares (Canada) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Hudbay Minerals Inc. Ordinary Shares (Canada) trades at $26.07 (market cap $11.24B). The key difference: Halozyme Therapeutics Inc. Common Stock and Hudbay Minerals Inc. Ordinary Shares (Canada) are close in size by market cap, and Hudbay Minerals Inc. Ordinary Shares (Canada) pays a 0.11% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Hudbay Minerals Inc. Ordinary Shares (Canada) for 1 Days on average.

HALOHBM
Market Cap
$12.58B$11.24B
Volume
2,179,2784,316,374
Sector
HealthBasic Materials
52-Week High
$115.22$31.87
52-Week Low
$61.63$14.58
Typical Hold Time
1 Days1 Days
Enterprise Value
$14.49B$11.30B
Dividend Yield
—0.11%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →

About Hudbay Minerals Inc. Ordinary Shares (Canada)

Hudbay Minerals is a mining company producing copper, gold, zinc, and other metals. Its operations are located in the Americas.

Read more on HBM →